Koyfin Home > Directory > Health Care > Acorda Therapeutics > Cost of Goods Sold

Acorda Therapeutics Cost of Goods Sold Chart (ACOR)

Acorda Therapeutics annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Acorda Therapeutics Cost of Goods Sold for the quarter ending June 06, 2020 was $7m a -19.95% decrease of -1m year over year
  • Acorda Therapeutics Cost of Goods Sold for the last 12 months ending June 06, 2020 was $27m a -81.66% decrease of -22m year over year
  • Acorda Therapeutics Annual Cost of Goods Sold for 2019 was $35m a -180.18% decrease of -63m from 2018
  • Acorda Therapeutics Annual Cost of Goods Sold for 2018 was $98m a -14.66% decrease of -14m from 2017
  • Acorda Therapeutics Annual Cost of Goods Sold for 2017 was $112m a 3.44% increase of 4m from 2016
Other Income Statement Metrics:
  • Acorda Therapeutics EBITDA for the quarter ending December 12, 2018 was $-14m a 190.76% decrease of -26m year over year
  • Acorda Therapeutics Net Income for the quarter ending December 12, 2018 was $10m a 185.45% increase of 18m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Cost of Goods Sold Data

06/2020$7m
03/2020$4m
12/2019$9m
09/2019$8m
06/2019$9m
03/2019$9m
12/2018$21m
09/2018$25m
06/2018$30m
03/2018$21m

Annual ACOR Cost of Goods Sold Data

2019$35m
2018$98m
2017$112m
2016$108m
2015$93m
2014$81m
2013$67m
2012$58m
2011$54m
2010$36m